Skip to main content
. 2018 Jan 11;19(1):226. doi: 10.3390/ijms19010226

Figure 2.

Figure 2

Dot plots of marker results in urine. Comparison of marker concentrations in urinary samples from clinical controls and bladder tumor patients. (a) Survivin and (b) UBC® Rapid. Lines depict the median for each group. p-Values were obtained from the Wilcoxon signed-rank test.